| 2026-08-13 | Press release | MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial o |
| 2026-08-06 | Press release | MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, |
| 2026-08-06 | Press release | MiNK Therapeutics Presents Early Observations from Ongoing Phase 2 Trial at the 2026 Military Health System Research Sym |
| 2026-06-03 | Press release | MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting |
| 2026-05-28 | Press release | MiNK Therapeutics Announces First Patient Dosed in Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critic |
| 2026-05-20 | Press release | MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clin |
| 2026-05-15 | Press release | MiNK Therapeutics Reports First Quarter 2026 Financial Results and Advances iNKT Cell Therapy Platform Into Randomized C |
| 2026-05-14 | Press release | MiNK Therapeutics and First Lviv Territorial Medical Union Initiate Randomized Phase 2 Trial of agenT-797 in Acute Lung |
| 2026-05-12 | Press release | MiNK Therapeutics Presents Clinical Evidence That a Single, Off-the-Shelf, iNKT Cell Product Drives Context-Dependent Im |
| 2026-05-08 | Press release | MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therap |
| 2026-04-17 | Press release | MiNK Therapeutics Reports Phase II Data on Immune Reprogramming and Durable Survival in PD-1 Refractory Gastroesophageal |
| 2026-04-03 | Press release | MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gas |
| 2026-04-02 | Press release | MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy |
| 2026-04-01 | Press release | MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 Internation |
| 2026-03-31 | Press release | MiNK Therapeutics Reports Q4 and Full Year 2025 Results; Phase 2 Programs Advance with Impactful Non-Dilutive Momentum |
| 2026-03-17 | Press release | MiNK Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Highlight Platform Expansion Across |
| 2026-03-10 | Press release | MiNK Therapeutics Announces Collaboration with C-Further to Advance PRAME-Targeted iNKT Cell Therapy for Pediatric Cance |
| 2026-02-03 | Press release | MiNK Therapeutics Presents New Data of allo-iNKT Cell Therapy as a Potential Disease-Modifying Approach in Idiopathic Pu |
| 2026-01-08 | Press release | MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-7 |
| 2025-05-05 | Press release | MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report |
| 2024-12-18 | Press release | MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer at ASCO GI Annual Meeting |
| 2024-09-03 | Press release | MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference |
| 2024-05-14 | Press release | MiNK Reports First Quarter 2024 Results |
| 2024-04-30 | Press release | MiNK to Provide Corporate Update and First Quarter 2024 Financial Report |
| 2024-03-21 | Press release | MiNK Reports Fourth Quarter and Year-End 2023 Results |
| 2024-03-07 | Press release | MiNK to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report |
| 2023-11-09 | Press release | MiNK Therapeutics Reports Third Quarter 2023 Results |
| 2023-10-30 | Press release | MiNK to Provide Third Quarter 2023 Financial Report and Corporate Update |
| 2023-08-10 | Press release | MiNK Therapeutics Reports Second Quarter 2023 Results |
| 2023-07-28 | Press release | MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update |
| 2023-05-11 | Press release | MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results |
| 2023-04-27 | Press release | MiNK Therapeutics to Report First Quarter 2023 Corporate Update and Financial Results |
| 2023-03-21 | Press release | MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results |
| 2023-03-07 | Press release | MiNK Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results |
| 2022-11-03 | Press release | MiNK Therapeutics Reports Corporate Update and Third Quarter 2022 Financial Results |
| 2022-10-20 | Press release | MiNK Therapeutics to Report Third Quarter 2022 Financial Results and Business Update |
| 2022-08-09 | Press release | MiNK Therapeutics Reports Corporate Update and Second Quarter 2022 Financial Results |
| 2022-07-27 | Press release | MiNK Therapeutics to Report Second Quarter 2022 Financial Results and Business Update |
| 2022-05-10 | Press release | MiNK Therapeutics Corporate Update and First Quarter 2022 Financial Report |
| 2022-04-27 | Press release | MiNK Therapeutics to Report First Quarter 2022 Financial Results and Business Update |